Effect of Attention Training on Attention Bias Variability and PTSD Symptoms: Randomized Controlled Trials in Israeli and U.S. Combat Veterans.
Effect of Attention Training on Attention Bias Variability and PTSD Symptoms: Randomized Controlled Trials in Israeli and U.S. Combat Veterans.
复制标题
DOI:
10.1176/appi.ajp.2015.14121578
复制
发表时间:
2015-12
期刊:
影响因子:
--
通讯作者:
Bar-Haim Y
中科院分区:
文献类型:
--
作者:
Badura-Brack AS;Naim R;Ryan TJ;Levy O;Abend R;Khanna MM;McDermott TJ;Pine DS;Bar-Haim Y
Attention allocation to threat is perturbed in patients with posttraumatic stress disorder (PTSD), with some studies indicating excess attention to threat and others indicating fluctuations between threat vigilance and threat avoidance. The authors tested the efficacy of two alternative computerized protocols, attention bias modification and attention controltraining, for rectifying threat attendance patterns and reducing PTSD symptoms. Two randomized controlled trials compared the efficacy of attention bias modification and attention control training for PTSD: one in Israel Defense Forces veteransand one in U.S. military veterans. Both utilized variants of the dot-probe task, with attention bias modification designed to shift attention away from threat and attention control training balancing attention allocation between threat and neutral stimuli. PTSD symptoms, attention bias, and attention bias variability were measured before and after treatment. Both studies indicated significant symptom improvement after treatment, favoring attention control training. Additionally, both studies found that attention control training, but not attention bias modification, significantly reduced attention bias variability. Finally, a combined analysis of the two samples suggested that reductions in attention bias variability partially mediated improvement in PTSD symptoms. Attention control training may address aberrant fluctuations in attention allocation in PTSD, thereby reducing PTSD symptoms. Further study of treatment efficacy and its underlying neurocognitive mechanisms is warranted. ClinicalTrials.gov registration identifiers: NCT01368302, NCT01564667.
登录
查看更多内容
影响因子:
4.6
作者:
Constans, JI;McCloskey, MS;Mathews, A
通讯作者:
Mathews, A
影响因子:
3.3
作者:
Iacoviello BM;Wu G;Abend R;Murrough JW;Feder A;Fruchter E;Levinstein Y;Wald I;Bailey CR;Pine DS;Neumeister A;Bar-Haim Y;Charney DS
通讯作者:
Charney DS
影响因子:
10.6
作者:
Hakamata, Yuko;Lissek, Shmuel;Bar-Haim, Yair;Britton, Jennifer C.;Fox, Nathan A.;Leibenluft, Ellen;Ernst, Monique;Pine, Daniel S.
通讯作者:
Pine, Daniel S.
影响因子:
12.8
作者:
Cisler JM;Koster EH
通讯作者:
Koster EH
影响因子:
3.7
作者:
Beard C;Sawyer AT;Hofmann SG
通讯作者:
Hofmann SG